Related Experiment Video
Updated: Sep 27, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Treatment of coronary stent thrombosis with rheolytic thrombectomy: results from a multicenter experience
Jose A Silva1, Christopher J White, Stephen R Ramee
1Alton Ochsner Medical Institutions, New Orleans, Louisiana, USA. jsilva@ochsner.org
Insights
Rheolytic thrombectomy (RT) is a safe and effective treatment for coronary stent thrombosis, significantly reducing thrombus burden and improving blood flow. This intervention offers better outcomes than traditional methods for this serious complication.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Device Technology
Background:
- Coronary stent thrombosis is a rare but severe complication of percutaneous coronary intervention.
- Conventional treatments for stent thrombosis often yield suboptimal results.
- There is a need for more effective therapeutic options.
Purpose of the Study:
- To evaluate the feasibility, efficacy, and safety of rheolytic thrombectomy (RT) for treating coronary stent thrombosis.
- To compare outcomes of RT with historical data for conventional treatments.
Main Methods:
- Retrospective analysis of 18 patients with coronary stent thrombosis treated with RT.
- Assessment of device and procedure success rates.
- Evaluation of angiographic outcomes, including thrombus burden and coronary flow (TIMI grades).
- Monitoring of in-hospital and 30-day major adverse cardiovascular events (MACE).
Main Results:
- High rates of device (94%) and procedure (100%) success were achieved with RT.
- Significant reduction in angiographic thrombus area post-RT (P < 0.001).
- Restoration of TIMI 3 coronary flow in 94.4% of patients.
- Low incidence of procedural complications and no major adverse events at 30-day follow-up.
Conclusions:
- Adjunctive rheolytic thrombectomy is feasible, effective, and safe for managing coronary stent thrombosis.
- RT demonstrates improved outcomes compared to historical treatments for this complication.
- Rheolytic thrombectomy should be strongly considered as a treatment option for coronary stent thrombosis.
Abstract:
The objective of this study was to assess the feasibility, efficacy, and safety of rheolytic thrombectomy (RT) for treatment of coronary stent thrombosis. Stent thrombosis is an infrequent but potentially devastating complication. Conventional treatment with balloon angioplasty and/or thrombolysis has yielded suboptimal results. RT was used to treat 18 patients (mean age, 62 +/- 8 years; 72% male) with in-stent thrombosis (mean time to stent thrombosis, 2.4 +/- 1.8 days). Device success, procedure success, in-hospital and 30-day major cardiovascular events (MACE) were assessed in the hospital and at 30 days. Device success was obtained in 94% and procedure success was achieved in 100% of patients. Following RT, 11 patients underwent balloon angioplasty and 7 patients received additional stents. TIMI 3 coronary flow was obtained in 94.4% and all (100%) patients achieved either TIMI 2 or 3 coronary flow. The angiographic thrombus area decreased from 113.7 +/- 79 to 5.5 +/- 5.7 mm(2) after RT, and to 0.9 +/- 2.1 mm(2) (P < 0.001) after final treatment. Procedural complications were limited to transient no-reflow in five patients. Only one patient evolved a Q-wave MI. At 30 days of follow-up, no patients suffered death, emergent bypass surgery, or stroke. Our data suggest that the adjunctive use of rheolytic thrombectomy offers improved outcomes compared to prior results of intervention after coronary stent thrombosis and should be strongly considered as a treatment option for this complication.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care